In our present study, we have shown for the first time that EVs originated from NFAT3-expressing poorly aggressive luminal breast cancer cells are competent to alone inhibit triple breast cancer cell lines invasion and, in cooperation with macrophages, spheroids growth in vitro. The gene discussed is NFATC4; the disease is breast cancer.